Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Urology
Published in: World Journal of Urology 8/2019

01-08-2019 | Prostate Cancer | Topic Paper

Salvage lymphadenectomy in recurrent prostate cancer: is there evidence of real benefit?

Authors: F. Pisano, J. M. Gaya, A. Breda, J. Palou

Published in: World Journal of Urology | Issue 8/2019

Login to get access

Abstract

Purpose

Nodal recurrent prostate cancer (PCa) after primary radical treatment represents a heterogeneous entity with many treatment options. In some cases, surgical removal of metastatic nodes seems to improve cancer control and delay systemic treatments. The objectives of this study were to analyze the available literature on salvage lymphadenectomy for the treatment of nodal recurrent PCa and to elucidate the real oncological benefit deriving from this procedure.

Methods

A PubMed search was performed using the following terms: prostate cancer, metastatic, oligometastatic, salvage lymphadenectomy, salvage lymph node dissection, salvage lymph node excision, and cytoreductive surgery. We included in the study all papers on salvage lymphadenectomy in nodal recurrent PCa, with no temporal limits. In addition, several papers addressing cytoreductive surgery and the biology of oligometastatic disease, published in different medical and basic research journals, were included.

Results

Salvage lymphadenectomy is still characterized by a lack of standardization in patient selection and surgical template. Its primary objectives are to prolong progression-free survival and to delay the need for systemic therapy. The improvements in preoperative imaging techniques in conjunction with the wide use of minimally invasive surgery have generated growing interest in this procedure.

Conclusion

Salvage lymphadenectomy is a promising treatment approach; however, its real oncological benefit is still far from proven. Prospective randomized trials need to be designed to improve understanding of this issue.
Literature
1.
2.
Ost P, Bossi A, Decaestecker K et al (2015) Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol 67:852–863CrossRef
3.
Giovacchini G, Picchio M, Gracia-Parra R et al (2014) [11C]Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen deprivation therapy. J Nucl Med 55:233–241CrossRef
4.
Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65:467–479CrossRef
5.
6.
Heldenreich A, Moul JW, Shariat SF et al (2016) Role of salvage lymph node dissection in prostate cancer. Curr Opin Urol 26:581–589CrossRef
7.
Froehner M (2011) Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 117:2577 (author reply 2577–8)CrossRef
8.
Sivaraman A, Benfante N, Touijer K et al (2018) Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? Investig Clin Urol 59:83–90CrossRef
9.
Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin N Am 28:555–565CrossRef
10.
Suardi N, Gandaglia G, Gallina A et al (2015) Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Eur Urol 67:299–309CrossRef
11.
Abdollah F, Briganti A, Montorsi F et al (2015) Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy. Eur Urol 67:839–849CrossRef
12.
Rigatti P, Suardi N, Briganti A et al (2011) Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Eur Urol 60:935–943CrossRef
13.
14.
Abreu A, Fay C, Park D et al (2017) Robotic salvage retroperitoneal and pelvic lymph node dissection for ‘node-only’ recurrent prostate cancer: technique and initial series. BJU Int 120:401–408CrossRef
15.
Montorsi F, Gandaglia G, Fossati N et al (2017) Robot-assisted salvage lymph node dissection for clinically recurrent prostate cancer. Eur Urol 72:432–438CrossRef
16.
Treglia G, Ceriani L, Sadeghi R et al (2014) Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis. Clin Chem Lab Med 52:725CrossRef
17.
Mamede M, Ceci F, Castellucci P et al (2013) The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level < 0.5 ng/mL. Clin Nucl Med 38:342–345CrossRef
18.
Scattoni V, Picchio M, Suardi N et al (2007) Detection of lymph-node metastases with integrated [11C] choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 52:423–429CrossRef
19.
Mitchell CR, Lowe VJ, Rangel LJ et al (2013) Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. J Urol 189:1308–1313CrossRef
20.
Passoni NM, Suardi N, Abdollah F et al (2014) Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series. Urol Oncol 32:38e9–16
21.
Oderda M, Joniau S, Palazzetti A et al (2018) Is 11C-choline positron emission tomography/computed tomography accurate to detect nodal relapses of prostate cancer after biochemical recurrence? A multicentric study based on pathologic confirmation from salvage lymphadenectomy. Eur Urol Focus 4:288–293CrossRef
22.
Mena E, Lindenberg ML, Shih JH et al (2017) Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy. Eur J Nucl Med Mol Imaging 45:4–11CrossRef
23.
24.
Porres D, Pfister D, Thissen A et al (2017) The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer. Prostate Cancer Prostatic Dis 20:85–92CrossRef
25.
Rauscher I, Maurer T, Beer AJ et al (2017) Value of 68 Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy. J Nucl Med 57:1713–1719CrossRef
26.
Siriwardana A, Thompson J, van Leeuwen PJ et al (2017) Initial multicentre experience of68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited. BJU Int 120:673–681CrossRef
27.
Jilg CA, Rischke HC, Reske SN et al (2012) Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer. J Urol 188:2190–2197CrossRef
28.
29.
Evans JD, Jethwa KR, Ost P et al (2018) Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease. Pract Radiat Oncol 8:28–39CrossRef
30.
Ost P, Bossi A, Decaestecker K et al (2015) Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol 67:852–863CrossRef
31.
Rinnab L, Mottaghy FM, Simon J et al (2008) [11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer: preliminary results of a prospective study. Urol Int 81:191–197CrossRef
32.
Karnes RJ, Murphy CR, Bergstralh EJ et al (2015) Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. J Urol 193:111–116CrossRef
33.
34.
Tilki D, Mandel P, Seeliger F et al (2015) Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy. J Urol 193:484–490CrossRef
35.
Zattoni F, Nehra A, Murphy CR et al (2016) Mid-term outcomes following salvage lymph node dissection for prostate cancer nodal recurrence status post-radical prostatectomy. Eur Urol Focus 2:522–531CrossRef
36.
Herlemann A, Kretschmer A, Buchner A et al (2017) Salvage lymph node dissection after 68 Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients. Oncotarget 8:84180–84192CrossRef
Metadata
Title
Salvage lymphadenectomy in recurrent prostate cancer: is there evidence of real benefit?
Authors
F. Pisano
J. M. Gaya
A. Breda
J. Palou
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 8/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02844-1

Other articles of this Issue 8/2019

World Journal of Urology 8/2019 Go to the issue

Original Article

Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma

Topic Paper

Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review

Original Article

Long-term follow-up after cystectomy for bladder pain syndrome: pain status, sexual function and quality of life

Original Article

Perceptions of dietary factors promoting and preventing nephrolithiasis: a cross-sectional survey

Original Article

Prospective evaluation of the performances of narrow-band imaging flexible videoscopy relative to white-light imaging flexible videoscopy, in patients scheduled for transurethral resection of a primary NMIBC

Topic Paper

Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study